UGT2B17 and metabolic dysfunction-associated steatotic liver disease: It was observed that SOAT2, DGAT2, DGKB, LIPC, CETP, NR0B2, CACNA1H, ADCY1, AKR1D1, SULT1E1, UGT2B17, CYP26A1, and CYP26B1 showed interactions in NAFLD vs. cirrhosis group (Figure 1(i)).